Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengmai capsule
- Development stage
- Phase 3
- Lead developer
- Guang'anmen Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shengmai capsule is a traditional Chinese medicine (TCM) formulation composed of Radix ginseng, Radix ophiopogonis, and Fructus schisandrae in a 1:2:1 ratio. It is primarily indicated for the treatment of coronary heart disease, specifically for patients exhibiting "qi-yin" deficiency. In clinical research conducted at Guang'anmen Hospital of China Academy of Chinese Medical Sciences, the capsule has been evaluated for its ability to improve clinical syndromes and modulate inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP), endothelin-1 (ET-1), matrix metalloproteinase-9 (MMP-9), and homocysteine in patients with unstable angina pectoris following percutaneous coronary intervention (PCI). The formulation is designed to replenish qi, nourish yin, and promote the production of body fluids, thereby supporting cardiovascular recovery and reducing post-procedural inflammation.
- Brand names
- Shengmai capsule
- Other names
- Sheng Mai CapsulesShengmai yinSM capsules
02
Targets
ET-1 (Endothelin-1)MMP9 (Matrix metalloproteinase-9)
Beyond the preview
Go deeper on Shengmai capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengmai capsule.